Concurrent antitumor and bone-protective effects of everolimus in osteotropic breast cancer.

about

In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets.mTORC1 impedes osteoclast differentiation via calcineurin and NFATc1

P2860

Q52314292-9F847616-7EFB-45FD-BE3E-9F5EC822F306 Q57146434-BBCE54EE-3B10-406F-ABD8-CEC6F05EF3A5

P2860

Concurrent antitumor and bone-protective effects of everolimus in osteotropic breast cancer.

Item

http://www.wikidata.org/entity/Q38631833

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Concurrent antitumor and bone- ...... in osteotropic breast cancer.

@en

type

Item

label

Concurrent antitumor and bone- ...... in osteotropic breast cancer.

@en

prefLabel

Concurrent antitumor and bone- ...... in osteotropic breast cancer.

@en

P1476

Concurrent antitumor and bone- ...... in osteotropic breast cancer.

@en

P2093

Andrew J Browne

http://www.w3.org/2001/XMLSchema#string

Andy Göbel

http://www.w3.org/2001/XMLSchema#string

David Chen

http://www.w3.org/2001/XMLSchema#string

Friedrich Stölzel

http://www.w3.org/2001/XMLSchema#string

Lorenz C Hofbauer

http://www.w3.org/2001/XMLSchema#string

Marie L Kubasch

http://www.w3.org/2001/XMLSchema#string

Martina Rauner

http://www.w3.org/2001/XMLSchema#string

Peyman Hadji

http://www.w3.org/2001/XMLSchema#string

Tilman D Rachner

http://www.w3.org/2001/XMLSchema#string

P2860

mTOR signaling in growth control and disease

Analysis of mTOR Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K-AKT-mTOR Pathway Inhibitors.

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

Metastasis to bone: causes, consequences and therapeutic opportunities

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer

Murine models of breast cancer bone metastasis

Bisphosphonates and bone quality.

Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer.

Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system.

Breast cancer metastasis to the bone: mechanisms of bone loss

P2888

s13058-017-0885-7

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13058-017-0885-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091133363

http://www.w3.org/2001/XMLSchema#string

P698

28793923

http://www.w3.org/2001/XMLSchema#string

P932

5551016

http://www.w3.org/2001/XMLSchema#string

Concurrent antitumor and bone-protective effects of everolimus in osteotropic breast cancer.

about

P2860

P2860

Concurrent antitumor and bone-protective effects of everolimus in osteotropic breast cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932